Forget the horse-race coverage. With seven weeks until November 3, the election math for the House is about as clear as it gets. Democrats have an 8-in-10 chance of securing a majority in the U.S. House of Representatives this fall, according to a Sept. 3 Cornell forecast unveiled at the American Political Science Association meeting that says its model has correctly predicted winners of the previous 14 congressional elections. Prediction markets are even more decisive: Polymarket’s implied probability for Democrats winning the House has been around the low 90s in recent days, reflecting the market’s collective view at any given moment.
Democrats are seeking to reclaim the House majority after coming close in recent cycles. They need a net gain of three seats to reach 218 and secure the majority. That is not a long-shot number. And yet most portfolio repositioning conversations are still treating November as a coin flip. That gap is an opportunity.
Where the Leverage Actually Lives
Given the potential of a split Congress, a Democratic majority in the House and a narrow Republican victory in the Senate, this November is “much more important for individual stocks, sub-industries, and sectors,” says Dan Clifton, a top-ranked analyst who leads Strategas’ Washington policy team. Even without a full Democratic sweep, a Democratic House gains something concrete: committee chairmanships, subpoena power, and a blocking position on future spending cuts. That matters enormously for two sectors that have been priced as if the current policy environment is permanent.
The first is healthcare. The One Big Beautiful Bill Act is projected by the Congressional Budget Office to reduce Medicaid and SNAP benefits by about $1.0 trillion over 2025 to 2034, with Medicaid the main driver. Centene’s stock has already suffered badly. Its shares fell sharply after the company said it would take longer than planned to rebuild profits in its Medicaid business, and management said federal policy changes will mute margin recovery through 2027. There will probably be delays and carve-outs around the law’s Medicaid provisions as implementation fights move to the states, the agencies, and Congress. The beneficiaries would be Medicaid managed-care insurers like Centene and hospitals with meaningful Medicaid exposure, including Tenet Healthcare. A Democratic House cannot reverse the law outright, but it can use spending negotiations and the 2027 debt ceiling to force modifications.
Then there is the debt ceiling in 2027. Having to raise the debt ceiling with a split government changes the dynamics of the leverage. If the Democrats have complete control, they can use that ceiling and budget to get policy changes, like fewer cuts to food stamps and Medicaid, or more renewable energy spending. That is not speculative. It is how divided governments have operated for decades.
Clean Energy: Already Drafted, Waiting for a Majority
The second sector is renewable energy. Congressional Democrats have not waited until after the election to signal their agenda. In addition to re-upping clean energy credits introduced in the Inflation Reduction Act of 2022, Democratic proposals and oversight efforts have focused on restoring or protecting clean-energy grant funding that the Trump administration moved to rescind after the 2025 budget law and ensuing reviews. It is unlikely major clean-energy expansions would pass in a Republican-controlled Congress. However, they can serve as a foundation for future legislation if Democrats regain the House or Senate in the November midterms.
The One Big Beautiful Bill had already tightened the screws: it accelerated and restricted several energy tax provisions, and IRS guidance reflects a July 4, 2026, begin-construction deadline for certain wind and solar facilities to remain eligible for key federal credits under the new regime. Companies like First Solar, which derives meaningful margin from IRA-era manufacturing incentives, and grid infrastructure suppliers are effectively pricing in a permanently hostile policy regime. A Democratic House changes that calculus.
The Risk Worth Naming
While Trump would still have to sign any legislation, control of one chamber would hand Democrats command over key committees, giving them the power to launch investigations and call administration officials to Capitol Hill for public hearings. That dynamic alone introduces volatility for industries currently benefiting from light regulatory oversight.
The core insight is directional, not binary. Centene and Tenet have already absorbed years’ worth of bad news. Clean energy equities are priced for continued hostility. A Democratic House does not guarantee a policy reversal, but it raises the floor. For investors willing to look past November 3, both sectors offer asymmetric exposure to an outcome the odds now favor.
